AlphaFold predicted structure
GANAB · Q14697

Mean pLDDT
92.9/ 100
Very high
944 residues
Confidence breakdown
- Very high(≥ 90)89%
- Confident(70–90)2%
- Low(50–70)3%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glucosidase II alpha subunit
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Cystic kidney disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDuctal plate malformation
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPolycystic liver disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownpolycystic kidney disease 3 with or without polycystic liver disease
autosomal dominant polycystic liver disease
Isolated polycystic liver disease
autosomal dominant polycystic kidney disease
Biliary tract abnormality
COVID-19
severe acute respiratory syndrome
hereditary disease
phototoxic dermatitis
mathematical ability
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Neutral alpha-glucosidase AB
Catalytic subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for PKD1/Polycystin-1 and PKD2/Polycystin-2 maturation and localization to the cell surface and cilia (PubMed:27259053)
GANAB · Q14697

Mean pLDDT
92.9/ 100
Very high
944 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0